AU2011207061B2 - Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof - Google Patents

Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof Download PDF

Info

Publication number
AU2011207061B2
AU2011207061B2 AU2011207061A AU2011207061A AU2011207061B2 AU 2011207061 B2 AU2011207061 B2 AU 2011207061B2 AU 2011207061 A AU2011207061 A AU 2011207061A AU 2011207061 A AU2011207061 A AU 2011207061A AU 2011207061 B2 AU2011207061 B2 AU 2011207061B2
Authority
AU
Australia
Prior art keywords
naproxen
formulation
ranges
weight
nsaid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011207061A
Other languages
English (en)
Other versions
AU2011207061A1 (en
Inventor
Christina Armstrong
Peter Draper
Nancy Klassen
John Lopez
Sankalp Vashishtha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Ontario Ltd
Original Assignee
Catalent Ontario Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Ontario Ltd filed Critical Catalent Ontario Ltd
Publication of AU2011207061A1 publication Critical patent/AU2011207061A1/en
Application granted granted Critical
Publication of AU2011207061B2 publication Critical patent/AU2011207061B2/en
Assigned to CATALENT ONTARIO LIMITED reassignment CATALENT ONTARIO LIMITED Request to Amend Deed and Register Assignors: ACCUCAPS INDUSTRIES LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011207061A 2010-01-19 2011-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof Active AU2011207061B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,690,488 2010-01-19
CA2690488A CA2690488C (en) 2010-01-19 2010-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
PCT/CA2011/000059 WO2011088553A1 (en) 2010-01-19 2011-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof

Publications (2)

Publication Number Publication Date
AU2011207061A1 AU2011207061A1 (en) 2012-07-26
AU2011207061B2 true AU2011207061B2 (en) 2015-05-28

Family

ID=44303618

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011207061A Active AU2011207061B2 (en) 2010-01-19 2011-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof

Country Status (13)

Country Link
US (4) US9480667B2 (OSRAM)
EP (2) EP2525789B1 (OSRAM)
JP (2) JP5975884B2 (OSRAM)
AU (1) AU2011207061B2 (OSRAM)
CA (1) CA2690488C (OSRAM)
DK (1) DK2525789T3 (OSRAM)
ES (1) ES2880813T3 (OSRAM)
HU (1) HUE055771T2 (OSRAM)
MX (1) MX358636B (OSRAM)
PL (1) PL2525789T3 (OSRAM)
PT (1) PT2525789T (OSRAM)
SI (1) SI2525789T1 (OSRAM)
WO (1) WO2011088553A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
JP2017516823A (ja) * 2014-06-04 2017-06-22 ディグニティ サイエンシス リミテッド Ｄｇｌａを含む薬学的組成物及びその使用
CN104083339A (zh) * 2014-08-04 2014-10-08 人福普克药业（武汉）有限公司 萘普生钠软胶囊及其制备方法
US10368284B2 (en) * 2014-11-12 2019-07-30 T-Mobile Usa, Inc. Quality of experience-based handover management
WO2016181221A1 (en) 2015-05-13 2016-11-17 Dignity Sciences Limited Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
JP2018520197A (ja) 2015-07-21 2018-07-26 アフィミューン リミテッド 癌及び神経疾患の治療または予防において使用するための、１５−ｈｅｐｅを含む組成物
CA3008774C (en) 2015-12-18 2021-10-12 Afimmune Limited Compositions comprising 15-hepe and methods of using the same
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
CN109692127A (zh) * 2019-03-15 2019-04-30 王征 一种密封小胶囊的制备方法
CN113950324A (zh) * 2019-04-26 2022-01-18 R.P.谢勒技术有限公司 微型软胶囊萘普生组合物
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
US20220233452A1 (en) * 2021-01-25 2022-07-28 R.P. Scherer Technologies, Llc Mini softgel naproxen composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2600023A1 (en) * 2005-03-08 2006-09-14 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
CN1130354A (zh) 1993-09-07 1996-09-04 普罗克特和廿保尔公司 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
SK96196A3 (en) * 1994-01-24 1997-03-05 Procter & Gamble Process for solubilizing difficultly soluble pharmaceutical actives
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
CA2318128C (en) * 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
US20090318558A1 (en) * 2003-02-12 2009-12-24 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate
US7582679B2 (en) 2006-02-03 2009-09-01 Pharmaceutics International Incorporated Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US20110052679A1 (en) * 2009-08-25 2011-03-03 Pharmaceutics International, Inc. Solid naproxen concentrates and related dosage forms

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2600023A1 (en) * 2005-03-08 2006-09-14 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents

Also Published As

Publication number Publication date
EP2525789B1 (en) 2021-06-02
MX358636B (es) 2018-08-29
US20170020832A1 (en) 2017-01-26
US11896566B2 (en) 2024-02-13
CA2690488C (en) 2013-06-11
HUE055771T2 (hu) 2021-12-28
PT2525789T (pt) 2021-07-19
JP5975884B2 (ja) 2016-08-23
EP3909567A1 (en) 2021-11-17
CA2690488A1 (en) 2011-07-19
JP2016094462A (ja) 2016-05-26
DK2525789T3 (da) 2021-07-19
MX2012008300A (es) 2012-11-23
US20130011470A1 (en) 2013-01-10
AU2011207061A1 (en) 2012-07-26
WO2011088553A1 (en) 2011-07-28
EP2525789A1 (en) 2012-11-28
PL2525789T3 (pl) 2022-01-03
ES2880813T3 (es) 2021-11-25
EP2525789A4 (en) 2014-04-30
US20240139132A1 (en) 2024-05-02
US9480667B2 (en) 2016-11-01
US20200046662A1 (en) 2020-02-13
JP2013517304A (ja) 2013-05-16
SI2525789T1 (sl) 2021-12-31
US10463637B2 (en) 2019-11-05

Similar Documents

Publication Publication Date Title
US11896566B2 (en) Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
AU701771B2 (en) Gelatin capsules containing a high concentrated acetaminophen solution
WO2009066146A2 (en) Stable solutions of sparingly soluble actives
US20030232097A1 (en) Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
WO2009069139A1 (en) Dosage form providing an ibuprofen-containing liquid fill
US6551615B1 (en) Dexibuprofen-containing soft gelatin capsules and process for preparing the same
WO2005046727A2 (en) Ibuprofen-containing soft gelatin capsules
AU2002356421A1 (en) Dexibuprofen-containing soft gelatin capsules and process for preparing the same
WO2003013481A1 (en) The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients
JP4394447B2 (ja) アセトアミノフェン組成物
WO2016084099A1 (en) Soft gelatin capsule composition of anti-tussive agents
WO2014060855A1 (en) Pharmaceutical compositions of diclofenac or salts thereof
WO2014060856A1 (en) Pharmaceutical compositions of diclofenac or salts thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: CATALENT ONTARIO LIMITED

Free format text: FORMER NAME(S): ACCUCAPS INDUSTRIES LIMITED